Literature DB >> 8886511

Markers for cardiovascular and renal morbidity: expectations for an intervention programme in an Australian aboriginal community.

W E Hoy1, R McFarlane, D J Pugsley, R Norman, J D Mathews.   

Abstract

1. Australian Aborigines have high rates of both cardiovascular mortality and renal failure and the usual male dominance in these conditions is respectively reduced and effaced. 2. In one Aboriginal community, we have demonstrated a strong association between albuminuria and cardiovascular risk factors and a relationship of both with insulin resistance, which is more pronounced in females than males. 3. We propose that albuminuria is a component of Syndrome X and that reduction in levels of albuminuria should prove to be a useful marker of effectiveness in treatment programmes targeting cardiovascular risk as well as renal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886511     DOI: 10.1111/j.1440-1681.1996.tb03039.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.

Authors:  T M Davis; F Daly; J P Walsh; K F Ilett; J P Beilby; L J Dusci; P H Barrett
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

Review 2.  Addressing cardiovascular inequalities among indigenous Australians.

Authors:  Alex Brown
Journal:  Glob Cardiol Sci Pract       Date:  2012-09-10

Review 3.  From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.

Authors:  Luis Vitetta; Anthony W Linnane; Glenda C Gobe
Journal:  Toxins (Basel)       Date:  2013-11-07       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.